Opzelura – SEP Display Banners HCP Wallboard Extension – 34626

Vitiligo, a chronic condition characterized by loss of skin pigmentation, can impact patients’ psychological wellbeing, according to clinical research. Studies show that vitiligo has been associated with generalized anxiety and...

Pediatric patients with vitiligo responded well to 308-nm laser treatment, with the best retention of re-pigmentation for facial lesions, according to a study published in the Journal of Drugs and Dermatology. Sumit Sethi, MBBS,...

Among different ethnic groups, knowledge of and attitudes toward vitiligo varies, according to a study published in the Journal of Cosmetic Dermatology. Premjit Juntongjin, MD, and colleagues assessed knowledge and attitudes...

The FDA has approved Opzelura (ruxolitinib) as the first topical treatment for vitiligo. The 1.5% cream is approved for continuous topical use twice daily to affected areas of up to 10% of body surface area in patients aged 12...

For patients with acral vitiligo, the combination of fractional ablative CO2 and 5 fluorouracil (5FU) cream proved effective and safe, according to a study published in the Journal of Cosmetic Dermatology. Ragia Weshahy, PhD,...

In a recent Wall Street Journal article, the authors equate teaching future doctors about “diversity, equity, and inclusion competencies” to “political re-education” and “wokeness.” They claim that “hyper-class and -racial...